UPDATE: RDIF confirms to sell 100 mln doses of Sputnik V vaccine to India
(Adds details in lede, comments in last two paragraphs)
MOSCOW, Sep 16 (PRIME) -- The Russian Direct Investment Fund (RDIF) confirmed on Wednesday it had agreed to sell 100 million doses of the Sputnik V anti-coronavirus vaccine to an Indian pharmaceuticals company.
The fund said it had agreed with Dr. ReddyТs Laboratories Ltd on cooperation for clinical research and the supply of the Sputnik V vaccine to India.
УAfter receiving regulatory approval, 100 million doses of the Sputnik V vaccine will be supplied to the country ... Deliveries may begin at the end of 2020 after receiving the results of clinical trials and registration of the vaccine in India,Ф the RDIF said.